Target intelligence / Profile preview

ATP-binding cassette sub-family A member 3 (ABCA3)

Target
ABCA3
Molecular classification
Transporter (ATP-binding cassette transporter), ABC transporter superfamily, ABC1 subfamily (also called sub-family A)
01

Overview

ATP-binding cassette sub-family A member 3 (ABCA3) is a multi-membrane spanning lipid transporter essential for surfactant production in the lungs. ABCA3 specifically mediates the ATP-dependent import of major phospholipids into lamellar bodies within alveolar type II cells. These phospholipids are then processed with surfactant proteins to produce functional surfactant, which lowers alveolar surface tension and prevents lung collapse. Mutations in ABCA3 result in abnormal surfactant metabolism and underlie several hereditary and pediatric pulmonary diseases, most notably surfactant metabolism dysfunction type 3 and idiopathic pulmonary fibrosis. ABCA3 is structurally related to other ABC transporters including CFTR but possesses unique domains and is not currently targeted by approved drugs. Its function is indispensable for respiratory health, and genetic defects are associated with high mortality in neonates.

Other names
ABC transporter 3ABC3ABC-CABC-C transporterABCA3_HUMANATP-binding cassette transporter 3ATP-binding cassette, sub-family A (ABC1), member 3SMDP3
02

Mechanism of action

Potential mechanisms would include: Modulation of ABCA3 transporter function to restore lipid transport and surfactant metabolism. Correction of mutant protein trafficking or function (this is the approach in CFTR modulation and may theoretically apply for ABCA3). No compounds of this type are approved for ABCA3, so this is largely theoretical.

03

Biological functions

Pulmonary surfactant production (transport of phospholipids into lamellar bodies)Surfactant homeostasis and regulationLipid transport (phosphatidylcholine, phosphatidylglycerol, sphingomyelin, cholesterol, phosphatidylethanolamine, phosphatidylserine)Positive regulation of phospholipid effluxEngulfment during programmed cell death (proposed)May contribute to cellular responses to xenobiotics
04

Disease associations

Surfactant metabolism dysfunction type 3 (monogenic, severe/fatal neonatal respiratory distress and/or pediatric interstitial lung disease)Idiopathic pulmonary fibrosisCataract-microcornea syndromeOther hereditary lung diseases associated with ABCA3 mutations
05

Safety considerations

Mutations in ABCA3 can result in life-threatening neonatal respiratory distress, pediatric interstitial lung disease, and early death.The heterogeneity of mutations makes pharmacological rescue challenging.Severe cases are often resistant to standard therapeutic approaches including mechanical ventilation, surfactant replacement, and immunosuppression.The target’s essential physiological role in lung tissue means off-target modulation could have severe pulmonary consequences.
06

Interacting drugs

No drugs are currently approved or widely recognized as direct modulators of ABCA3 function. However, there is some clinical interest in the mechanism of CFTR modulators (e.g., ivacaftor) due to shared conserved domains, though these are not used for ABCA3 disease and this target is not currently drugged in the clinic.
07

Biomarkers

Presence of ABCA3 gene mutations in genetic testing for suspected surfactant dysfunctionMeasurement of surfactant composition in alveolar lavage or tissue

Beyond the preview

Go deeper on ATP-binding cassette sub-family A member 3 (ABCA3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP-binding cassette sub-family A member 3 (ABCA3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call